Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A

Oncogene

Volumn 23, Issue 28, 2004, Pages 4930-4937

  Tonini, Tiziana ^a,b   Bagella, Luigi ^a,b   D'Andrilli, Giuseppina ^a   Claudio, Pier Paolo ^a,c   Giordano, Antonio ^a,b,d  

^a TEMPLE UNIVERSITY   (United States)

^b UNIVERSITY OF SIENA   (Italy)

^c Dept Sci Odontostomatologiche M ^*  (Italy)

^d Temple University   (United States)

Author keywords

Ezh2; Polycomb; pRb2 p130

Indexed keywords

CYCLIN A; DNA; ENHANCER OF ZESTE HOMOLOG 2 PROTEIN; HISTONE DEACETYLASE; PROTEIN; PROTEIN P130; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; EZH2 PROTEIN, HUMAN; EZH2 PROTEIN, MOUSE; HDAC1 PROTEIN, HUMAN; RBL2 PROTEIN, HUMAN; RBL2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CONTROLLED STUDY; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RETINOBLASTOMA; ANIMAL; BREAST TUMOR; CELL LINE; CELL STRAIN 3T3; FEMALE; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM; PLASMID; PROSTATE; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALIA;

3T3 CELLS; ANIMALS; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CYCLIN A; DNA-BINDING PROTEINS; FEMALE; HISTONE DEACETYLASES; HUMANS; MALE; MICE; PLASMIDS; PROSTATE; PROSTATIC NEOPLASMS; PROTEINS; RETINOBLASTOMA-LIKE PROTEIN P130; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 3042848975     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207608     Document Type: Article

References (56)

1. Andrews NC and Faller DV. (1991). Nucleic Acids Res., 19, 2499.
2. Bardos JI, Saurin AJ, Tissot C, Duprez E, and Freemont PS. (2000). J. Biol. Chem., 275, 28785-28792.
3. Bellan C, De Falco G, Tosi GM, Lazzi S, Ferrari F, Morbini G, Bartolomei S, Toti P, Mangiavacchi P, Cevenini G, Trimarchi C, Cinti C, Giordano A, Leoncini L, Tosi P and Cottier H. (2002). Invest. Ophthalmol. Vis. Sci., 43, 3602-3608.
4. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E. and Helin K. (2003). EMBO J., 22, 5323-5335.
5. Carbone M, Rizzo P and Pass HI. (1997). Oncogene, 15, 1877-1888.
6. Claudio PP, Tonini T and Giordano A. (2002a). Genome Biol., 3, reviews3012.
7. Claudio PP, Zamparelli A, Garcia FU, Claudio L, Ammirati G, Farina A, Bovicelli A, Russo G, Giordano GG, McGinnis DE, Giordano A. and Cardi G. (2002b). Clin. Cancer Res., 8, 1808-1815.
8. Cohen KJ, Hanna JS, Prescott JE and Dang CV. (1996). Mol. Cell Biol., 16, 5527-5535.
9. De Luca A, Baldi A, Esposito V, Howard CM, Bagella L, Rizzo P, Caputi M, Pass H.I, Giordano GG, Baldi F, Carbone M and Giordano A. (1997a). Nat. Med., 3, 913-916.
10. De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Baldi A, Khalili K and Giordano A. (1997b). J. Biol. Chem., 272, 20971-20974.
11. Ewen ME, Xing YG, Lawrence JB. and Livingston DM. (1991). Cell, 66, 1155-1164.
12. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A and Trouche D. (1998). Proc. Natl. Acad. Sci. USA, 95, 10493-10498.
13. Fukuyama T, Otsuka T, Shigematsu H, Uchida N, Arima F, Ohno Y, Iwasaki H, Fukuda T. and Niho Y. (2000). Br. J. Haematol., 108, 842-847.
14. Galderisi U, Melone MA, Jori FP, Piegari E, Di Bernardo G, Cipollaro M, Cascino A, Peluso G, Claudio PP and Giordano A. (2001). Mol. Cell. Neurosci., 17, 415-425.
15. Gould A. (1997). Curr. Opin. Genet. Dev., 7, 488-494.
16. Guadagno TM and Newport JW. (1996). Cell, 84, 73-82.
17. Gunster MJ, Satijn DP, Hamer KM, den Blaauwen JL, de Bruijn D, Alkema MJ, van Lohuizen M, van Driel R and Otte AP. (1997). Mol. Cell. Biol., 17, 2326-2335.
18. Haupt Y, Alexander WS, Barri G, Klinken SP and Adams JM. (1991). Cell, 65, 753-763.
19. Hobert O, Jallal B and Ullrich A. (1996). Mol. Cell. Biol., 16, 3066-3073.
20. Jacobs JJ, Kieboom K, Marino S, DePinho RA and van Lohuizen M. (1999a). Nature, 397, 164-168.
21. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A and van Lohuizen M. (1999b). Genes Dev., 13, 2678-2690.
22. Kennison JA. (1995). Annu. Rev. Genet., 29, 289-303.
23. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA. and Chinnaiyan AM. (2003). Proc. Natl. Acad. Sci., 100, 11606-11611.
24. La Thangue NB. (1996). Biochem. Soc. Trans., 24, 54-59.
25. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY and Lee EY. (1987). Science, 235, 1394-1399.
26. Macaluso M, Paggi MG and Giordano A. (2003). Oncogene, 22, 6472-6478.
27. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D and Harel-Bellan A. (1998). Nature, 391, 601-605.
28. Mayol X, Grana X, Saldi A, Sang N, Hu Q and Giordano A. (1993). Oncogene, 8, 2561-2566.
29. Muller J. (1995). EMBO J., 14, 1209-1220.
30. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D. (2000). Nature, 406, 747-752.
31. Pipas JM. (1992). J. Virol., 66, 3979-3985.
32. Pirrotta V. (1997a). Trends Genet., 13, 314-318.
33. Pirrotta V. (1997b). Curr. Opin. Genet. Dev., 7, 249-258.
34. Pirrotta V. (1998). Cell, 93, 333-336.
35. Pupa SM, Howard CM, Invernizzi AM, De Vecchi R, Giani C, Claudio PP, Colnaghi MI, Giordano A and Menard S. (1999). Oncogene, 18, 651-656.
36. Raaphorst FM, Van Kemenade FJ, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP and Meijer CJ. (2000). Am. J. Pathol., 157, 709-715.
37. Raschella G, Tanno B, Bonetto F, Negroni A, Amendola R and Paggi MG. (2001). Med. Pediatr. Oncol., 36, 104-107.
38. Raschella G, Tanno B, Bonetto F, Negroni A, Claudio PP, Baldi A, Amendola R, Calabretta B, Giordano A and Paggi MG. (1998). Cell Death Differ., 5, 401-407.
39. Rhodes DR, Sanda MG, Otte AP, Chinnaiyan AM and Rubin MA. (2003). J. Natl. Cancer Inst., 95, 661-668.
40. Sanseverino F, Torricelli M, Petraglia F and Giordano A. (2003). Cancer Biol. Ther., 2, 636-641.
41. Satijn DP and Otte AP. (1999a). Biochim. Biophys. Acta., 1447, 1-16.
42. Satijn DP and Otte AP. (1999b). Mol. Cell. Biol., 19, 57-68.
43. Schumacher A. and Magnuson T. (1997). Trends Genet., 13, 167-170.
44. Sellers WR and Loda M. (2002). Cancer Cell, 2, 349-350.
45. Sewalt RG, van der Vlag J, Gunster MJ, Hamer KM, den Blaauwen JL, Satijn DP, Hendrix T, van Driel R and Otte AP. (1998). Mol. Cell. Biol., 18, 3586-3595.
46. Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK. and Hamel PA. (1996). Crit. Rev. Biochem. Mol. Biol., 31, 237-271.
47. Simon J.. (1995). Curr. Opin. Cell. Biol., 7, 376-385.
48. Stiegler P, De Luca A, Bagella L and Giordano A. (1998). Cancer Res., 58, 5049-5052.
49. Tonini T, Hillson C and Claudio PP. (2002). J. Cell Physiol., 192, 138-150.
50. Tonini T, Rossi F and Claudio PP. (2003). Oncogene, 22, 6549-6556.
51. Turner BM. (1991). J. Cell Sci., 99 (Part 1), 13-20.
52. van der Vlag J and Otte AP. (1999). Nat. Genet., 23, 474-478.
53. van Kemenade FJ, Raaphorst FM, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP and Meijer CJ. (2001). Blood, 97, 3896-3901.
54. Van Lohuizen M, Frasch M, Wientjens E and Berns A. (1991). Nature, 353, 353-355.
55. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA and Chinnaiyan AM. (2002). Nature, 419, 624-629.
56. Visser HP, Gunster MJ, Kluin-Nelemans HC, Manders EM, Raaphorst FM, Meijer CJ, Willemze R and Otte AP. (2001). Br. J. Haematol., 112, 950-958.